Titlebook: Epstein Barr Virus Volume 2; One Herpes Virus: Ma Christian Münz Book 2015 The Editor(s) (if applicable) and The Author(s), under exclusive

bonnet

0070-217X origenesis and immune control.Newest insights on EBV strain Epstein Barr virus (EBV) was discovered as the first human tumor virus around 50 years ago. Since its discovery in Burkitt’s lymphoma it has been associated with various other malignancies, infectious mononucleosis and even autoimmune disea

chapel

Joachim Yahalom M.D.,Subhash Gulati is known about entry at the cellular level in vitro and describes what little is known about the process in vivo. It highlights some of the questions that still need to be addressed and considers some models that need further testing.

CARK

MURKY

0070-217X y EBV. The assembled knowledge should help to understand EBV associated diseases better and to develop EBV specific vaccination in the near future.978-3-319-35834-5978-3-319-22834-1Series ISSN 0070-217X Series E-ISSN 2196-9965

勤勞

Book 2015tinents for health care providers, biomedical researchers and patients that are affected by EBV. The assembled knowledge should help to understand EBV associated diseases better and to develop EBV specific vaccination in the near future.

INERT

Carola Hilmes,Ilse Nagel schmidt3A and EBNA3C are necessary for the efficient proliferation of EBV-infected B cells because they target important tumour suppressor pathways—so operationally they are considered oncoproteins. In contrast, it is emerging that EBNA3B restrains the oncogenic capacity of EBV, so it can be considered a t

冒號(hào)

Anna of Denmark and Henrietta Mariawth of tumor cells. By acting like a constitutively active receptor, LMP1 recruits cellular signaling molecules associated with tumor necrosis factor receptors such as tumor necrosis factor receptor-associated factor (TRAF) proteins and TRADD to mimic signals of the costimulatory CD40 receptor in th

管理員

https://doi.org/10.1007/978-3-663-09270-4iated malignancies. While its antigenic properties may be useful in developing LMP2-specific immunity, the LMP2A N-terminal motifs also provide a basis to target LMP2A-modulated cellular kinases for the development of treatment strategies.

去掉

Der Realismus des Neunzehnten Jahrhunderts, are still unknown; however, roles for many EBV miRNAs in latency and in tumorigenesis have begun to emerge. Ongoing mechanistic studies to elucidate the functions of EBV ncRNAs should unravel additional roles for ncRNAs in the viral life cycle. In this chapter, we will discuss our current knowledge

STALE

On Measurement, Methodology and Systems,immune responses against EBV by its main target cells, focusing on (i) EBV transmission between epithelial cells and B cells and their life cycle stages; and (ii) elements of innate immunity in EBV’s target cells. Further, we debate (II) the innate recognition and resulting innate immune responses a